SynthesisAlimentary pharmacology & therapeutics2022

Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease.

Mohammad Zamani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.